USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18047
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCucos, Victoria
dc.date.accessioned2021-09-30T09:31:22Z
dc.date.available2021-09-30T09:31:22Z
dc.date.issued2014
dc.identifier.citationCUCOS, Victoria. Viral keratitis. Diagnosis and treatment. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 193.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/18047
dc.descriptionState Medical and Pharmaceutical University ’’Nicolae Testemitanu” , Chisinau, Republic of Moldova
dc.description.abstractIntroduction: Herpes Simplex Virus (HSV) is a human virus spread worldwide. Today more than 90% of adults carry systemic antibodiesto HSV-1. Herpetic keratitis is the most common form of the HSV eye disease, counting for 50% to 90% of ocular herpes. This is the leading cause of comeal blindness among developed countries and the most common indications for comeal transplant. Purpose and objectives: To determine the diagnostic features and treatment outcomes for herpetic keratitis. Materials and methods: all records of the pacients diagnosted with herpetic keratitis from 2007 through 2013 at the Ophtalmological Department of Medical Centre “OVISUS" Chisinau, were retrospectively reviewed. Results: The study revealed 30 pacients diagnosted with herpetic keratitis from 2007 to 2013. The study grup was consisted of 21 female (70% ) with mean age 59,67±18,16 and 9 male (30%) with mean age 50,56±16,71. Evaluating the pacients by age groups it is noticed an rising trend through young adults age 20-30, and another peak among elders age 71-80. Also pacients showed comorbidities: hypertension-36,67%, diabetes-20% , diseases that affect immune system like viral respiratory infection-10%, HBV-10%, HCV-3,33% . The study group showed other ocular diseases: glaucom -16.67%, cataract-10%, artifakia-6,67% , myopia-6,67% , retinal degeneration-3,33%, macular dystrophy-3,33% ,blefaritis-3,33%, pterygium -3,33%. The most common complains recorded were: decreased visual acuity-93,33% , tearing-83,33%, photophobia-70% , ocular pain, conjunctival injection-66,67%, blepharospasm -33,33%. Ocular examination revealed the following manifestations of keratitis: herpetic epithelial keratitis-20% , herpetic stomal keratitis-20% , herpetic keratouveitis-33,33% , herpetic corneal ulcer-26,67%. Surgical treatment was performed on 30% of pacients with an increase of visual acuity for 33,33% of pacients. Overall 70% of pacients required: antiviral medication, topical antibiotics, immunomodulatory drugs, topical steroids and also showed a significantly greater improvement in visual acuity for 33,33% pacients. Conclusion: Current data suggest that herpetic keratitis affects more women than men, pacinets with decreased immunity, and both surgical treatment and medication therapy have a better outcome with an increased visual acuity.en_US
dc.language.isoenen_US
dc.publisherMinistry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Associationen_US
dc.relation.ispartofMedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldovaen_US
dc.subjectHerpes simplex virusen_US
dc.subjectherpetic keratitisen_US
dc.titleViral keratitis. Diagnosis and treatmenten_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2014

Files in This Item:
File Description SizeFormat 
VIRAL_KERATITIS._DIAGNOSIS_AND_TREATMENT.pdf1.13 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback